Predictions
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€0.95
27.09.23
27.09.23
€1.00
27.09.24
27.09.24
-0.53%
12.10.23
12.10.23
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Vinfast Auto Pte. Ltd
Start price
Target price
Perf. (%)
€10.80
27.09.23
27.09.23
-
27.09.24
27.09.24
-17.13%
04.10.23
04.10.23
Mereo Biopharma Group Ltd.
Start price
Target price
Perf. (%)
€1.26
26.09.23
26.09.23
-
26.09.24
26.09.24
-1.59%
01.10.23
01.10.23
Vortex Energy Corp.
Start price
Target price
Perf. (%)
€0.51
25.09.23
25.09.23
-
25.10.23
25.10.23
-34.90%
26.10.23
26.10.23
Innovative
Sustainability is very important
Could be worthwhile Investment >10% per year
High risks for its business
Vsblty Groupe Technolog. Corp.
Start price
Target price
Perf. (%)
€0.040
25.09.23
25.09.23
€0.50
25.09.24
25.09.24
-35.64%
02.11.23
02.11.23
Very capable Management
Some uniques
Very differentiated customer and product portfolio
Vinfast Auto Pte. Ltd
Start price
Target price
Perf. (%)
€13.37
25.09.23
25.09.23
-
25.09.24
25.09.24
-10.96%
01.10.23
01.10.23
Pliant Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.20
25.09.23
25.09.23
-
25.09.24
25.09.24
14.79%
02.10.23
02.10.23
Super League Enterprise Inc.
Start price
Target price
Perf. (%)
€2.48
22.09.23
22.09.23
-
22.09.24
22.09.24
-
02.06.24
02.06.24
Precision BioSciences Inc
Start price
Target price
Perf. (%)
€0.39
19.09.23
19.09.23
€2.81
19.09.24
19.09.24
-11.92%
13.02.24
13.02.24
Thyssenkrupp Nucera Ag&co.kgaa
Start price
Target price
Perf. (%)
€19.80
19.09.23
19.09.23
€25.00
19.09.24
19.09.24
-5.20%
27.09.23
27.09.23
Vinfast Auto Pte. Ltd
Start price
Target price
Perf. (%)
€16.25
19.09.23
19.09.23
€15.00
19.09.24
19.09.24
-24.31%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
positive Cash Flow expected
Top 10 in its market
Known brand
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€0.92
19.09.23
19.09.23
€1.00
19.09.24
19.09.24
3.93%
27.09.23
27.09.23
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.26
18.09.23
18.09.23
€1.00
18.09.24
18.09.24
-36.79%
13.09.24
13.09.24
Differentiated customer and product portfolio
Leading role in innovation
Revenue growth > 30% per year expected
Higher risks for its business
Groupon Inc.
Start price
Target price
Perf. (%)
€12.19
18.09.23
18.09.23
€16.00
31.05.25
31.05.25
-31.80%
12.11.23
12.11.23
Could be very worthwhile Investment >20% year